Patient Engagement in PTSD Treatment (PEP)
PEP
1 other identifier
interventional
427
1 country
1
Brief Summary
The goal of this clinical study is to improve the outcome of outpatient PTSD treatment at two clinics treating majority ethnic Danes and refugees with PTSD respectively. The study will consist of two similar randomized controlled trials. The main questions the study aims to answer are:
- Does an added motivation enhancement module as a precursor for PTSD treatment reduce dropout and increase treatment outcome?
- Does an added Shared Decision-Making session which facilitate individualized treatment yield a superior outcome compared to PTSD treatment and PTSD treatment supplemented by motivation enhancement? Participants are recruited at two different clinics, Psychotherapeutic Unit (PU) and Competence Centre for Transcultural Psychiatry (CTP). At PU the participants are randomized to one of two arms, and at CTP to one of three arms. One arm is the control group where participants will receive treatment as usual (TAU), one arm is the first intervention group where the participants will receive an Introductory PTSD module consisting of four sessions focusing on enhancing motivation for PTSD treatment, before continuing in TAU. The last arm is the second intervention group, which will only take place at CTP. Here the patient will receive the Introductory PTSD module followed by a session of Shared Decision Making, where the participant together with the MD decides which of four standardized treatment courses they will receive. The treatment for all patients will last between 8-13 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2024
CompletedFirst Posted
Study publicly available on registry
January 1, 2025
CompletedStudy Start
First participant enrolled
January 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 29, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2028
April 9, 2025
December 1, 2024
3.2 years
December 13, 2024
April 8, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
International Trauma Questionnaire (ITQ)
A brief, simply worded measure, focusing only on the core features of PTSD and CPTSD, and employs straightforward diagnostic rules, based on the International Classification of Diseases, 11th edition (ICD-11). Scoring range: 0-4, lower scores reflect better outcome
Change from baseline to end-of-treatment after approximately 10 months
Secondary Outcomes (13)
Readiness of Psychotherapy Index (RPI)
Change from baseline to after intervention after approximately 1,5 months
Hopkins Symptom Check List-25 (HSCL)
Change from baseline to end-of-treatment after approximately 10 months
Psychological Outcome Profiles questionnaire (PSYCHLOPS)
Change from baseline to end-of-treatment after approximately 10 months
World Health Organisation - 5 Well-being Index (WHO-5)
Change from baseline to end-of-treatment after approximately 10 months
Life Events Checklist for DSM-5 (LEC-5)
Administered once at the initial assessment
- +8 more secondary outcomes
Study Arms (3)
Treatment as usual (TAU)
ACTIVE COMPARATOR8-12 months of treatment Interventions: Behavioral: treamtent as usuan (TAU)
Introductory PTSD module + TAU
EXPERIMENTAL9-13 months of treatment An intervention with an introductory PTSD module consistent of four sessions focusing on motivation followed by TAU
Introductory PTSD module + one session of Shared Decision Making + individualised treatment
EXPERIMENTAL9-13 months of treatment Add-on introductory PTSD module and add-on patient-centred shared decision making session before continuing in the chosen standardised treatment.
Interventions
The Introductory PTSD module consist of four session focusing on motivation
A patient-centred shared decision making session where one of four standardised treatments can be chosen
Treatment as usual
One of four treatments Treatment as ususal Sessions with psychologists Sessions with nurses Sessions with medical doctors
Eligibility Criteria
You may not qualify if:
- Adults (18 years or older)
- PTSD pursuant to the ICD-10 research criteria
- Signed informed consent
- patients referred to "Main Level" treatment
- Severe psychotic disorder (defined as patients with an ICD-10 diagnosis F2x and F30.1-F31.9). Participants are excluded only if the psychotic experiences are assessed to be part of an independent psychotic disorder and not part of a severe PTSD and/or depression.
- Dependence syndrome of drugs or alcohol: Active dependence and use (F1x.24-F1x.26).
- Adult (18 years or older)
- Refugees or persons who have been family reunified with a refugee
- PTSD pursuant to the ICD-10 research criteria
- Psychological trauma experienced outside Denmark in the anamnesis. Trauma is imprisonment or detention with torture (according to the United Nations' definition of torture) or acts of cruel, inhuman and degrading treatment or punishment. Trauma can also be organised violence, long-term political persecution and harassment, or war and civil war experiences.
- Signed informed consent
- Severe psychotic disorder (defined as patients with an ICD-10 diagnosis F2x and F30.1-F31.9). Participants are excluded only if the psychotic experiences are assessed to be part of an independent psychotic disorder and not part of a severe PTSD and/or depression.
- Dependence syndrome of drugs or alcohol: Active dependence and use (F1x.24-F1x.26).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mental Health Centre Ballerup
Ballerup Municipality, Capital Region, 2750, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jessica Carlsson
Mental Health Services in th Capital Region, Denmark
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
December 13, 2024
First Posted
January 1, 2025
Study Start
January 2, 2025
Primary Completion (Estimated)
February 29, 2028
Study Completion (Estimated)
August 31, 2028
Last Updated
April 9, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share